Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

DISEASE CHARACTERISTICS:

* Histologically confirmed multiple myeloma or other B-cell malignancy including non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia, or amyloidosis

  * Non-Hodgkin's lymphoma with T-cell immunophenotypes included

PATIENT CHARACTERISTICS:

Age:

* 18 and over

Performance status:

* Karnofsky 60-100%

Life expectancy:

* Not specified

Hematopoietic:

* WBC at least 2,000/mm\^3 (unless due to disease)
* Platelet count at least 100,000/mm\^3 (unless due to disease)

Hepatic:

* Not specified

Renal:

* Not specified

Cardiovascular:

* LVEF at least 40%

Pulmonary:

* DLCO or FVC and FEV1 at least 50% of predicted unless due to restriction from volume loss secondary to disease

Other:

* HIV negative
* No overt infection or unexplained fever requiring broad spectrum antibiotics
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

Biologic therapy:

* At least 2 weeks since prior biologic therapy

Chemotherapy:

* At least 2 weeks since other prior chemotherapy and recovered

Endocrine therapy:

* At least 2 weeks since prior endocrine therapy
* Concurrent steroids allowed

Radiotherapy:

* Not specified

Surgery:

* Not specified